Sana Biotechnology (SANA) Goodwill & Intangibles (2020 - 2026)
Sana Biotechnology (SANA) posted Goodwill & Intangibles of $199.8 million for Q1 2026, little changed sequentially from $199.8 million in Q4 2025, and little changed YoY from $199.8 million in Q1 2025.
Analysis
Sana Biotechnology (SANA) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Goodwill & Intangibles for 7 years, with the latest figure at $199.8 million in Q1 2026.
- Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $199.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.8 million (changed 0.0% YoY) and the FY2025 annual result came in at $199.8 million, changed 0.0% from the prior year.
- Goodwill & Intangibles held at $199.8 million in Q1 2026 per SANA's latest filing, from $199.8 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $199.8 million in Q1 2022 and troughed at $199.8 million in Q1 2022.
- A 5-year average of $199.8 million and a median of $199.8 million in 2022 frame the typical range for Goodwill & Intangibles.
- The widest YoY moves for Goodwill & Intangibles: up 0.01% in 2022, down 0.0% in 2022.
- Over 5 years, Goodwill & Intangibles stood at $199.8 million in 2022, then changed by 0.0% to $199.8 million in 2023, then changed by 0.0% to $199.8 million in 2024, then changed by 0.0% to $199.8 million in 2025, then changed by 0.0% to $199.8 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $199.8 million, $199.8 million, and $199.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sana Biotechnology | 1.14 Bn | 1.14 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199.82 Mn |
| Mar 31, 2026 | 199.82 Mn |
| Dec 31, 2025 | 199.82 Mn |
| Sep 30, 2025 | 199.82 Mn |
| Jun 30, 2025 | 199.82 Mn |
| Mar 31, 2025 | 199.82 Mn |
| Dec 31, 2024 | 199.82 Mn |
| Sep 30, 2024 | 199.82 Mn |
| Jun 30, 2024 | 199.82 Mn |
| Mar 31, 2024 | 199.82 Mn |
| Dec 31, 2023 | 199.82 Mn |
| Sep 30, 2023 | 199.82 Mn |
| Jun 30, 2023 | 199.82 Mn |
| Mar 31, 2023 | 199.82 Mn |
| Dec 31, 2022 | 199.82 Mn |
| Sep 30, 2022 | 199.82 Mn |
| Jun 30, 2022 | 199.82 Mn |
| Mar 31, 2022 | 199.82 Mn |
| Dec 31, 2021 | 199.82 Mn |
| Sep 30, 2021 | 199.83 Mn |